A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
NCT04909034
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
NSCLC Stage IIIB~IV
Interventions
DRUG:
MS-20
DRUG:
Placebo
Sponsor
Microbio Co Ltd